Howe v. Ethicon, Inc.
- Nelson Roman
- 7:21-cv-02031
- U.S. District Court · Southern District of New York
- 42
In Howe v. Ethicon, Judge Roman so ordered a joint discovery plan for Rachel Howe’s medical-device product-liability case.
Rachel Howe, Ethicon, Inc., and Johnson & Johnson, whose discovery obligations and use of prior pelvic-mesh litigation materials are governed by the plan.
What happened
Howe v. Ethicon, Inc. concerns Rachel Howe’s claim for damages allegedly arising after implantation of an Ethicon surgical-mesh device. Ethicon, Inc. and Johnson & Johnson are the defendants.
The parties agreed to use discovery from related pelvic-mesh proceedings when possible, avoid duplicative general discovery, and conduct case-specific depositions and discovery under applicable federal and local rules. They also submitted proposed protective, scheduling, and pathology orders.
Judge Nelson S. Roman so ordered the civil case discovery plan on November 30, 2022. This filing set discovery procedures; it did not decide the merits of Howe’s product-liability claims.
The detailed version
- Howe v. Ethicon, Inc. · No. 7:21-cv-02031
- Nelson Roman
- Nov. 30, 2022
Background
This is a medical-device product-liability action seeking damages allegedly arising after Rachel Howe was implanted with a Gynecare TVT Retropubic surgical-mesh device manufactured by Ethicon, Inc. The plan states that Ethicon, Inc. is a wholly owned subsidiary of Johnson & Johnson and that the device was designed to treat stress urinary incontinence in women.
The parties jointly submitted a Civil Case Discovery Plan under Federal Rules of Civil Procedure 16 and 26(f), following the court’s August 24, 2022 order. The filing also included proposed protective, scheduling, and pathology orders, which were filed separately.
Discovery Arrangements
The parties agreed to be bound by an order governing discovery in federal pelvic-mesh cases outside the related multidistrict litigation, or MDL. They agreed, subject to a protective order and other stated conditions, to use the general discovery conducted in MDL No. 2327 and not repeat duplicative general discovery, including repetitive company-witness depositions. The plan preserved objections to the admissibility of documents and deposition testimony at trial and allowed discovery of matters not previously addressed in the MDL.
The parties also agreed to use, when possible, existing depositions of general-causation experts and current or former employees of Ethicon and Johnson & Johnson from the MDL or related state-court proceedings. Additional depositions could be sought for updated or supplemental expert opinions or testimony that had become outdated, although the defendants did not concede that supplemental depositions were needed. Experts who had already been deposed on a report generally would not be deposed again unless they provided new or supplemental opinions.
Case-specific depositions—including Howe, her treating physicians, friends and family members, case-specific experts, the defendants’ sales representatives, and other relevant witnesses—would proceed under the Federal Rules of Civil Procedure and the Southern District of New York’s local rules unless the parties agreed otherwise. The parties would work together to allocate deposition time between Howe and the defendants. Howe would use the defendants’ global document production from the MDL, and the parties agreed to submit a protective order and proposed scheduling order for the court’s consideration.
Court’s Action and Effect
The document concludes, “SO ORDERED,” and is signed by Judge Nelson S. Roman. The court therefore entered the parties’ joint discovery plan for this case. The filing establishes discovery procedures and incorporates referenced MDL-related arrangements; it does not resolve whether any party is liable or decide the merits of Howe’s product-liability claims.
Read the full 42-page opinion on CourtListener, the free public archive maintained by the Free Law Project.